Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for VX-960 intermediate via cyanation and resolution. High purity, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.
Patent CN108137530A details optical resolution for β-2-thienyl-alanine. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN101100428B details an eco-friendly boric acid catalyzed route for high-purity chiral diethyl tartrate, offering significant cost and environmental advantages for pharma supply chains.
Patent CN111763150B reveals a novel L-glutamic acid resolution method for high-purity sertraline, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN114436877A details a novel Sacubitril synthesis avoiding high-risk oxidation. Achieve cost reduction in cardiovascular drug manufacturing with scalable routes.
Patent CN113582982B reveals a novel chiral resolution and coupling route for Aprepitant, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN114394907A details a safer, scalable route for norepinephrine bitartrate, offering cost reduction in pharmaceutical manufacturing and reliable supply chain continuity.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Novel resolution process for chiral piperidine intermediates. Reduces steps and cost for pharmaceutical manufacturing. Reliable supply chain partner.
Patent CN100546969C details a cost-effective resolution method for 2-hydroxymethyl-3-phenylpropionic acid using N-Octylglucamine, offering high optical purity for pharmaceutical synthesis.
Patent CN103193779A based eszopiclone preparation method offers high purity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Novel patent CN105566319A details efficient moxifloxacin intermediate synthesis with high chiral purity and reduced costs for reliable supply chains.
Advanced synthesis of Barnidipine Hydrochloride via chiral resolution. High purity, scalable route for API manufacturing. Cost-effective solution for hypertension drugs.
Patent CN110845305A details a novel organoaluminum catalyst for high-yield L-menthol production, offering significant cost reduction and supply chain reliability for fine chemical manufacturers.
Patent CN1219758C reveals a scalable inclusion resolution method for di-tert-butyl thiosulfinate, offering dual-configuration access and significant cost reduction potential.
Patent CN1259941A details a streamlined route for 3-N,N-dicyclobutylamino-8-fluoro-benzopyran derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced catalytic reduction route for Rivastigmine Tartrate offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.